USD 3.3 billion
Report ID:
SQMIG35H2227 |
Region:
Global |
Published Date: February, 2024
Pages:
260
|Tables:
121
|Figures:
77
Global Single Use Bioreactors Market size was valued at USD 3.3 billion in 2022 and is poised to grow from USD 3.86 billion in 2023 to USD 13.66 billion by 2031, growing at a CAGR of 17.1% during the forecast period (2024-2031).
Single-use bioreactors have gained a huge significance as a storage accessory in the pharmaceutical and clinical industry mainly for cell harvesting, culturing, and filtration, media, and buffer, and virus inactivation. Technically, SUBs are disposable bags made of polyethylene and polymer and gamma-sterilized at suppliers end for common end-use. One of the major advantage of using a single-use bioreactor is it reduces the time spent on preparing the bioreactor for the next batch. The market size for SUBs is expected to rise owing to the rise in importance of cell storage and cultivation in the pharmaceutical industry.
In the upcoming years, it is expected that the adoption of disposable bioreactors will accelerate due to the rising demand for highly effective therapeutics that don't need a lot of bioreactors. Small-scale, bench-top SUBs reduce the need for assembling, cleaning, and autoclaving, which results in a quicker turnaround time. These reactors are regarded as the workhorses for process development and optimization, driving the adoption of SUBs for the development of biopharmaceuticals. SUBs also have the potential to be less expensive than traditional bioreactors. Disposable bioreactors typically have lower implementation costs than traditional stainless-steel bioreactor systems. Therefore, the benefits of these products' cost-savings in terms of construction, operation, and cleaning can be primarily blamed for their widespread adoption.
US Single Use Bioreactors Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 3.3 billion
Largest Segment
CROs & CMOs
Fastest Growth
CROs & CMOs
Growth Rate
17.1% CAGR
To get more reports on the above market click here to Buy The Report
Global Single Use Bioreactors Market is segmented by product, type of cell, molecule type, application, end-use, usage type and region. Based on product, the market is segmented into single-use bioreactor systems, single-use media bags, single-use assemblies and other related products. Based on type of cell, the market is segmented into mammalian cells, bacterial cells, yeast cells and other cells. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy and other molecules. Based on application, the market is segmented into research and development, process development and bioproduction. Based on end-use, the market is segmented into pharmaceutical and biopharmaceutical companies, academic and research institutes, contract research organizations (CROs) and contract manufacturing organizations (CMOs). Based on usage type, the market is segmented into lab-scale production, pilot-scale production and large-scale production. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on molecule type, monoclonal antibodies, vaccines, gene modified cells, stem cells and other molecule segments. Based on end-users the Single Use Bioreactors Market can be segregated into pharmaceutical & biopharmaceutical companies, CROs & CMOs, academic & research institutes sub segments. The regional insights of the market are into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.
Single Use Bioreactors Market Analysis by Product
The market segment with the largest revenue share of more than 80% is single-use bioreactor systems. Single-use bioreactor systems are now widely used in biopharmaceutical manufacturing processes that prioritize high product yield. Single-use bioreactors' flexibility, cost effectiveness, and high mass production will increase demand, which will have an effect on growth.
Due to these benefits, the market might experience a greater demand for quick development, increased production of new biotherapeutics like vaccines, antibodies, enzymes, and hormones, and an increase in the product quantities that can be produced in these bioreactors, all of which will help the market expand. Furthermore, the segment growth for the upcoming years will be boosted by key players' increased focus on offering small-scale bioreactors.
Single Use Bioreactors Market Analysis by End-Use
The CMOs and CROs segment generated the most revenue, with a share of over 35%. CMOs have a high demand for more flexible production capacity and quick campaign switchovers. They consequently use a wider variety of single-use parts and systems. CMOs and CROs are more likely to use SUBs as a result of the rising trend of outsourcing. This development is attributed to the effectiveness and usability of SUBs in managing various biopharmaceutical products and shifting market demands. These elements lead to significant SUS device penetration and quicker CMO adoption of new SUS technologies. The segment is being driven by CMOs' dynamic processing lines and facilities as well as more reliable product developers for bioprocessing machinery and infrastructure.
To get detailed analysis on other segments, Request For Free Sample Report
North America maintained a huge dominance and is expected to continue a leading position owing to the presence of significant operating players and the region's well-established biopharmaceutical industry. Additionally, the region's increased manufacturing capacity has added to the market expansion. For instance, Thermo Fisher Scientific announced in September 2021 that it intended to build a new manufacturing facility specifically for single-use bioprocessing products. The addition of the Nashville location increased its network of SUT manufacturing facilities on a global scale. The changing environment for manufacturing and bioprocessing is a key driver of market expansion in the United States.
Asia Pacific is projected to register the fastest CAGR throughout the forecast period. It is estimated that about 50% of the new bioprocessing facilities across the globe are being established by Asian companies, including domestic players and international giants. In the near future, this is anticipated to significantly drive the Asia Pacific market. Due to its widespread use of single-use technology, China is predicted to be at the forefront.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Single Use Bioreactors Market Drivers
Rise in geriatric population and need for workflow in biopharmaceuticals to boost market demand
Single Use Bioreactors Market Restraints
Lack of accurate information and compatibility to challenge the market growth
Request Free Customization of this report to help us to meet your business objectives.
The market is rapidly developing, and in the upcoming years, it is anticipated that market competition will rise. The increasing use of disposable bioreactors has led to an increase in new market entrants, which has in turn heightened competition. To maintain their market presence, the major market players are engaging in a number of strategic initiatives. One of the key strategies used by the major market players is the introduction of new products. Other key strategies include mergers and acquisitions and capacity expansion.
Single Use Bioreactors Market Top Players Company Profiles
Single Use Bioreactors Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to global single use bioreactors market analysis, the market segment with the largest revenue share of more than 80% is single-use bioreactor systems. Single-use bioreactor systems are now widely used in biopharmaceutical manufacturing processes that prioritize high product yield. The CMOs and CROs segment generated the most revenue, with a share of over 35%. CMOs have a high demand for more flexible production capacity and quick campaign switchovers. The largest revenue share, at over 30%, was earned by North America. This is explained by the presence of significant operating players and the region's well-established biopharmaceutical industry.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 3.3 billion |
Market size value in 2031 | USD 13.66 billion |
Growth Rate | 17.1% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Single Use Bioreactors Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Single Use Bioreactors Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Single Use Bioreactors Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Single Use Bioreactors Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2227
sales@skyquestt.com
USA +1 351-333-4748